DE69609501T2 - Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte - Google Patents

Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte

Info

Publication number
DE69609501T2
DE69609501T2 DE69609501T DE69609501T DE69609501T2 DE 69609501 T2 DE69609501 T2 DE 69609501T2 DE 69609501 T DE69609501 T DE 69609501T DE 69609501 T DE69609501 T DE 69609501T DE 69609501 T2 DE69609501 T2 DE 69609501T2
Authority
DE
Germany
Prior art keywords
sodium starch
starch glycolate
active substances
composition
products produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69609501T
Other languages
English (en)
Other versions
DE69609501D1 (de
Inventor
Fabio Carli
J Shah
Edward C Shinal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aptalis Pharma SRL
Original Assignee
Eurand International SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand International SpA filed Critical Eurand International SpA
Publication of DE69609501D1 publication Critical patent/DE69609501D1/de
Application granted granted Critical
Publication of DE69609501T2 publication Critical patent/DE69609501T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69609501T 1995-04-20 1996-04-17 Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte Expired - Lifetime DE69609501T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42543495A 1995-04-20 1995-04-20
PCT/IB1996/000492 WO1996032931A2 (en) 1995-04-20 1996-04-17 Composite with sodium starch glycolate as a support material and products thereof

Publications (2)

Publication Number Publication Date
DE69609501D1 DE69609501D1 (de) 2000-08-31
DE69609501T2 true DE69609501T2 (de) 2001-03-29

Family

ID=23686568

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609501T Expired - Lifetime DE69609501T2 (de) 1995-04-20 1996-04-17 Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte

Country Status (11)

Country Link
EP (1) EP0822808B1 (de)
JP (1) JPH11503749A (de)
AT (1) ATE194909T1 (de)
AU (1) AU5658496A (de)
CA (1) CA2218486A1 (de)
DE (1) DE69609501T2 (de)
DK (1) DK0822808T3 (de)
ES (1) ES2149471T3 (de)
GR (1) GR3034617T3 (de)
PT (1) PT822808E (de)
WO (1) WO1996032931A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1295289B1 (it) * 1997-10-07 1999-05-04 Telos S R L Co-macinati per uso cosmetico e dermatologico
EP1406728B1 (de) * 2001-06-29 2004-11-03 Eurand Pharmaceuticals Ltd. Verfahren zur arzneimittelaktivierung in einer schwingmühle
CA2450900C (en) 2001-06-29 2010-08-24 Eurand Pharmaceuticals Limited Drug activation process and vibrational mill therefor
WO2005012254A1 (en) 2003-07-22 2005-02-10 Arena Pharmaceuticals, Inc. Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related therto
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
EP2190844B3 (de) 2007-08-15 2013-07-17 Arena Pharmaceuticals, Inc. Imidazo[1,2-a]pyridinderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich für die behandlung von damit in zusammenhang stehenden erkrankungen eignen
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
SI2364142T1 (en) 2008-10-28 2018-06-29 Arena Pharmaceuticals, Inc. The modulators of the serotonin 5-HT2A receptor are useful in the treatment of disorders associated with it
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
ITMI20120092A1 (it) 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
MX2017016413A (es) 2015-06-12 2018-08-01 Axovant Sciences Gmbh Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamineto de un trastorno conductual del sueño rem.
MX2018000465A (es) 2015-07-15 2018-09-17 Axovant Sciences Gmbh Derivados de diaril y arilheteroaril urea como moduladores del receptor de serotonina 5-ht2a útiles para la profilaxis y el tratamiento de alucinaciones asociadas con una enfermedad neurodegenerativa.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5132719A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
US5130140A (en) * 1989-09-14 1992-07-14 Hoeschst-Roussel Pharmaceuticals Inc. Method of making direct dry compressible acetaminophen composition

Also Published As

Publication number Publication date
DE69609501D1 (de) 2000-08-31
GR3034617T3 (en) 2001-01-31
EP0822808B1 (de) 2000-07-26
AU5658496A (en) 1996-11-07
ES2149471T3 (es) 2000-11-01
JPH11503749A (ja) 1999-03-30
WO1996032931A3 (en) 1996-11-28
DK0822808T3 (da) 2000-10-09
ATE194909T1 (de) 2000-08-15
EP0822808A2 (de) 1998-02-11
WO1996032931A2 (en) 1996-10-24
PT822808E (pt) 2000-12-29
CA2218486A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
DE69609501T2 (de) Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte
UY24875A1 (es) Composiciones farmacéuticas conteniendo tetrahidrolipstatina
AU7915898A (en) Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration
AP1954A (en) Controlled release compositions comprising nimesulide.
AU7001001A (en) Modified forms of pharmacologically active agents and uses therefor
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
AU6329600A (en) Foot prosthesis
CA2185512A1 (en) Treatment of Tinnitus Using Neuroprotective Agents
ATE223712T1 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
ATE197903T1 (de) Peptid-kohlenwasserstoff konjugate, welche t-zell immunität bewirken
IL158899A0 (en) Pharmaceutical compositions for inhibiting angiogenesis containing oleuropein and derivatives thereof
DE69433355D1 (de) Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate
AR021806A1 (es) COMPOSICIoN FARMACÉUTICA EN FORMA DE TABLETA QUE COMPRENDE ENTACAPONA Y MÉTODO DE PREPARACIoN.
BG103714A (en) Pararacetamol-containing tablet
FR2729857B1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
AU8025998A (en) Biologically active materials
TW200503689A (en) Pharmaceutical compositions of atorvastatin
AU3445489A (en) Luminide and macroluminide class of pharmaceuticals
DE69813263D1 (de) Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
AU5685300A (en) Solid preparations containing paroxetine
ES2165509T3 (es) Composiciones terapeuticas efervescentes.
FR2797446B1 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: EURAND INTERNATIONAL S.P.A., MAILAND/MILANO, IT

8364 No opposition during term of opposition
R081 Change of applicant/patentee

Ref document number: 822808

Country of ref document: EP

Owner name: APTALIS PHARMA S.R.L., IT

Free format text: FORMER OWNER: EURAND INTERNATIONAL S.P.A., MAILAND/MILANO, IT

Effective date: 20110824

R082 Change of representative

Ref document number: 822808

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, 81925 MUENCHEN, DE

R082 Change of representative

Ref document number: 822808

Country of ref document: EP

Representative=s name: HOFFMANN - EITLE, 81925 MUENCHEN, DE